Related Experiment Video
Updated: May 9, 2026

Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip
Published on: February 16, 2024
Current status and prospects for development of a vaccine against Trichomonas vaginalis infections
Jeffrey Smith1, Gary E Garber2
1University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada.
Abstract:
Trichomonas vaginalis is a sexually transmitted pathogen with an annual worldwide incidence of over 276 million infections, the highest of all curable and non-viral STI. A large proportion of cases are asymptomatic and under-diagnosed with conventional diagnostic tools. Infection has important maternal and fetal health consequences and can lead to a higher probability of HIV transmission and susceptibility. Lack of affordable accurate diagnostic tests globally and metronidazole resistance hinder T. vaginalis control efforts. Based on data from current vaccination studies in animal models, a human vaccine is achievable to intervene on the substantial incidence of infection.
Related Concept Videos
Sexually Transmitted Infections
Microorganisms in Medicine and Therapeutics
Microbiota of the Urogenital Tract
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Human Virome

